On Friday, Wolfe Research revised its rating for Fortive Corporation (NYSE:FTV) stock, shifting from "Outperform" to "Peer Perform." This change follows Fortive's recent announcement regarding its intention to spin off its Productivity Technologies (PT) segment, which includes businesses such as Tektronix, Pacific Scientific, and Sensing.
The PT segment is projected to generate around $2.3 billion in sales this year, with an EBITDA of approximately $612 million, indicating a 27.2% margin. This segment accounts for about 32% of Fortive's total earnings.
The company's decision to restructure is aimed at streamlining its operations by consolidating its Industrial Scientific and Automation & Specialty businesses, both of which have significant recurring revenue models, while separating the more cyclical PT portfolio.
The PT segment has shown modest core growth at 2.5% from 2018 through the estimated year 2024, despite achieving a notable cumulative operating margin expansion of 460 basis points, roughly 50% of which are incremental.
Wolfe Research's downgrade reflects the implications of the spinoff on Fortive's business structure. The PT business's performance, while generating substantial margins, has not experienced high growth, which may impact Fortive's overall valuation post-spinoff. The completion of this strategic move is anticipated to occur in the fourth quarter of 2025.
The restructuring is expected to allow Fortive to focus on its Industrial Scientific and Automation & Specialty segments, which offer more stable revenue streams. The spinoff of the PT segment is part of a broader trend among conglomerates to streamline their business portfolios and concentrate on areas with more predictable earnings.
Investors and market watchers will be keeping an eye on Fortive's progress as it prepares for this significant organizational change. The company's stock performance and strategic direction in the coming months will likely reflect the ongoing preparations for the PT segment's spinoff and the market's reaction to this structural adjustment.
In other recent news, Fortive Corporation has sustained a Buy rating from TD Cowen and an Outperform rating from Baird, based on its strategic decisions, including a planned corporate breakup and a focus on stock buybacks.
Fortive's Q2 revenues stood at $1.52 billion, marking a 2% increase year-over-year, with earnings per share at $0.93, slightly exceeding consensus estimates. Truist Securities and RBC Capital adjusted their price targets for Fortive following these results.
In addition, Fortive announced its plans to spin off its Precision Technologies segment into a new public company, NewCo, expected to be completed by the end of 2025. This move aims to streamline Fortive's business portfolio and enhance its core growth.
Leadership changes will accompany the spin-off, with Olumide Soroye becoming President and CEO of Fortive, and Tami Newcombe stepping into the role of President and CEO of NewCo.
Fortive's Advanced Sterilization Products division, in partnership with PENTAX Medical, has also received FDA clearance for its new ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology.
This new sterilization method uses hydrogen peroxide gas plasma to sterilize duodenoscopes, aiming to enhance patient safety in healthcare settings. These are the recent developments in Fortive's business operations and strategies.
InvestingPro Insights
As Fortive Corporation (NYSE:FTV) prepares for the spinoff of its Productivity Technologies segment, the company's financial health and market valuation are critical factors for investors. According to InvestingPro data, Fortive boasts an impressive gross profit margin of 59.67% over the last twelve months as of Q2 2024, which is a testament to the company's ability to manage costs effectively and maintain profitability. The company's operating income margin during the same period stands at 18.97%, indicating strong operational efficiency.
Despite the Wolfe Research downgrade, one of the InvestingPro Tips suggests that analysts predict Fortive will be profitable this year, aligning with the company's history of profitability over the last twelve months. However, investors should note that Fortive is trading at a high P/E ratio of 28.88, which is considered high relative to its near-term earnings growth. With 13 analysts having revised their earnings downwards for the upcoming period, this could signal caution regarding the company's future earnings potential.
For those looking to delve deeper into Fortive's financials and future prospects, additional InvestingPro Tips are available, which could provide further insights into the company's valuation and performance metrics. As of now, there are 6 more tips listed on InvestingPro for Fortive, accessible at: https://www.investing.com/pro/FTV.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.